Can Zoloft (sertraline) cause dizziness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Zoloft Cause Dizziness?

Yes, Zoloft (sertraline) commonly causes dizziness both during treatment and upon discontinuation, and this is a well-documented adverse effect that clinicians must anticipate and manage proactively.

Dizziness During Active Treatment

Dizziness is explicitly listed as a typical side effect of SSRIs, including sertraline, in clinical practice guidelines 1. Approximately 63% of patients receiving second-generation antidepressants experience at least one adverse effect during treatment, with dizziness being among the commonly reported symptoms alongside diarrhea, dry mouth, fatigue, headache, and nausea 1.

  • The FDA drug label for sertraline specifically warns that dizziness can occur during treatment and lists it as a potential symptom requiring monitoring 2.
  • In clinical trials examining zolpidem (though not sertraline directly), meta-analyses showed a small but measurable increase in dizziness risk (0.06 risk difference) compared to placebo, demonstrating that CNS-active medications commonly produce this effect 1.

Dizziness Upon Discontinuation

The most clinically significant dizziness associated with sertraline occurs when the medication is stopped abruptly or tapered too quickly 2.

  • The FDA label explicitly warns that stopping sertraline too quickly may cause serious symptoms including "headache, sweating, nausea, dizziness, electric shock-like sensations, shaking, confusion" 2.
  • During marketing surveillance, spontaneous reports of adverse events upon SSRI discontinuation have consistently included dizziness, particularly when cessation is abrupt, along with dysphoric mood, irritability, agitation, sensory disturbances, anxiety, and confusion 2.
  • Sertraline and paroxetine are the SSRIs most implicated in discontinuation-related dizziness because they have short half-lives and high selectivity for serotonin 3.

Mechanism of Discontinuation Dizziness

The vestibular nucleus complex (VNC) contains abundant serotonin receptors, and abrupt SSRI withdrawal causes a sudden decrease in serotonin levels in this region 3. This disrupts bilateral VNC neuronal function, producing dizziness that is exacerbated by head movement, indicating a vestibular origin rather than simple lightheadedness 3.

Clinical Management Strategies

During Treatment

  • Monitor patients for dizziness, particularly during the first few weeks of treatment or when doses are adjusted 2.
  • Assess for orthostatic hypotension, as sertraline withdrawal has been documented to cause orthostatic hypotension with dizziness in case reports 4.
  • Rule out serotonin syndrome if dizziness occurs with other symptoms such as agitation, tremor, tachycardia, or confusion, especially if sertraline is combined with other serotonergic medications 2, 5.

Upon Discontinuation

A gradual dose reduction rather than abrupt cessation is mandatory to minimize discontinuation symptoms 2.

  • If intolerable symptoms occur following dose reduction, resume the previously prescribed dose and then decrease more gradually 2.
  • The guideline recommendation for discontinuing antidepressants is to taper over 10 to 14 days to limit withdrawal symptoms 1.
  • For patients experiencing severe discontinuation symptoms, an extended titration period may be necessary 4.

Important Caveats

  • Paradoxically, sertraline has been studied as a treatment for chronic subjective dizziness, with 73% of patients showing improvement in dizziness symptoms when treated with sertraline for vestibular disorders or psychogenic dizziness 6, 7. This therapeutic effect should not be confused with sertraline's potential to cause dizziness as an adverse effect.
  • Patients with CNS deficits may be more vulnerable to dizziness from sertraline compared to those with peripheral vestibular conditions 7.
  • When combined with other CNS depressants (such as lorazepam), sertraline may cause additive effects including increased sedation and dizziness, requiring dose adjustments 8.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Serotonin reuptake inhibitors for dizziness with psychiatric symptoms.

Archives of otolaryngology--head & neck surgery, 2002

Guideline

Lorazepam and Escitalopram Drug Interactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.